AAAAI: Omalizumab as effective as multifood oral immunotherapy for individuals with food allergy

by | Mar 7, 2026 | Health

Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at 12 months after multifood oral immunotherapy (mOIT) or omalizumab, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments